Russell Investments Group Ltd. Has $12.65 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Russell Investments Group Ltd. lowered its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 666,314 shares of the medical instruments supplier’s stock after selling 47,935 shares during the quarter. Russell Investments Group Ltd.’s holdings in DENTSPLY SIRONA were worth $12,647,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the business. Riverview Trust Co acquired a new position in DENTSPLY SIRONA during the 4th quarter worth about $26,000. MassMutual Private Wealth & Trust FSB lifted its position in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,232 shares in the last quarter. UMB Bank n.a. lifted its position in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 1,568 shares during the last quarter. Finally, Signaturefd LLC increased its holdings in shares of DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier’s stock valued at $84,000 after purchasing an additional 3,706 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Down 7.4 %

XRAY opened at $12.65 on Friday. The firm’s fifty day moving average is $16.34 and its two-hundred day moving average is $19.25. The firm has a market cap of $2.52 billion, a PE ratio of -6.11, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a twelve month low of $12.18 and a twelve month high of $32.83. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 5.06%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Analyst Ratings Changes

XRAY has been the topic of a number of recent research reports. Mizuho decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research report on Thursday, March 13th. Evercore ISI reiterated an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Barrington Research cut their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. Finally, Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average price target of $23.33.

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.